Protection of CD33-modified hematopoietic stem cell progeny from CD33-directed CAR T cells in rhesus macaques.

Saved in:
Bibliographic Details
Title: Protection of CD33-modified hematopoietic stem cell progeny from CD33-directed CAR T cells in rhesus macaques.
Authors: Petty NE; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Medical Scientist Training Program, University of Washington School of Medicine, Seattle, WA., Radtke S; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA., Kanestrom G; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA., Fields E; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA., Humbert O; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA., Fiorenza S; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA., Llewellyn MJ; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA., Laszlo GS; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA., Thomas J; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Medical Scientist Training Program, University of Washington School of Medicine, Seattle, WA., Burger Z; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA., Swing K; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA., Zhu H; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA., Jerome KR; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA., Turtle CJ; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA., Walter RB; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA., Kiem HP; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA.
Source: Blood advances [Blood Adv] 2025 May 27; Vol. 9 (10), pp. 2367-2378.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-9537
DOI:10.1182/bloodadvances.2024015016